Compare AstraZeneca plc (AZN) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Advanced Drainage Systems Inc — how do they compare? AstraZeneca plc trades at $158.54 (market cap $248.14B), while Advanced Drainage Systems Inc trades at $140.13 (market cap $10.83B). The key difference: AstraZeneca plc is far larger — about 22.9× Advanced Drainage Systems Inc's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | WMS | |
|---|---|---|
Market Cap | $248.14B | $10.83B |
Sector | Health | Industrials |
52-Week High | $209.48 | $175.38 |
52-Week Low | $147.06 | $129.50 |
Enterprise Value | $275.41B | $12.44B |
Dividend Yield | 2.01% | 0.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $157.39, down 2.79% amid bearish technical signals and merger speculation. The company demonstrates strong fundamentals with revenue growth to $58.74B in 2025 and a net income margin of 17.02%. Recent earnings have consistently beaten estimates, and analyst consensus is positive with 47.5% buy ratings. However, news of potential merger talks with Bristol Myers Squibb and a related legal investigation have introduced volatility.
The outlook is mixed; solid profitability and growth support long-term value, but near-term price pressure from technical indicators and merger uncertainty presents a cautious entry point. Key risks include deal execution challenges and integration complexities should a merger proceed.
Advanced Drainage Systems (WMS) trades at $141.67, down 1.58% with bearish technical signals. The company demonstrates strong profitability with 14% net margins and consistent earnings beats, though revenue growth has moderated. Recent Q1 2027 results showed 21% sales growth to $1 billion, beating expectations. Technical indicators show resistance at $143 with support at $140, while moving averages signal bearish momentum.
WMS offers solid fundamentals with attractive upside to the $185.86 consensus target, but faces near-term technical headwinds. The company's water management solutions benefit from infrastructure spending, though competitive pressures and margin compression present risks. Analyst sentiment is mixed with 41% buy ratings, suggesting cautious optimism for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
